| Sandoz Pharmaceuticals AG - Diaphin 5 g i.v., Pulver zur Herstellung einer Injektionslösung |
| 55561 | | 03 | | Diaphin 5 g i.v. | | Pulver zur Herstellung einer Injektionslösung | | N07BC06 | | Diamorphine | | 29.07.2021 | | |
|
| Composition |
| diamorphini hydrochloridum monohydricum 5 g corresp. diamorphinum 4.357 g pro vitro. |
| Packungsbestandteile |
| Dry substance | | | | | | | | Active Agent | Dose |
|---|
| Diamorphini Hydrochloridum Monohydricum | 5 g correspond Diamorphine 4.357 g |
| | BAG: Active Agent | Dose |
|---|
| Diamorphini Hydrochloridum Monohydricum | 5 g |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 8 | 152.00 | 165.30 | A+ | SL | Yes |
|
